Alberto De la Cuadra-Grande (Alberto de la Cuadra-Grande)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Benign Prostatic Hyperplasia

Electronic Health Record

Lower Urinary Tract Symptoms

Top Venues

Journal of clinical medicine

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Beatriz Álvarez-Álvarez, Laura Prieto-Pérez, Alberto De la Cuadra-Grande, Miguel Ángel Casado, Alfonso Cabello Úbeda, Aws W Al-Hayani, Irene Carrillo Acosta, Ignacio Mahillo Fernández, Miguel Górgolas Hernández-Mora, Jose M Benito, Norma Rallón
The Era of DAAs: Assessing the Patients' Characteristics, Clinical Impact, and Emergence of Comorbidities in HIV/HCV-Coinfected versus HIV-Infected Individuals. Journal of clinical medicine 13 (13) (2024)
Beatriz Álvarez-Álvarez, Laura Prieto-Pérez, Alberto De la Cuadra-Grande, Miguel Ángel Casado, Alfonso Cabello Úbeda, Aws W Al-Hayani, Irene Carrillo Acosta, Ignacio Mahillo Fernández, Miguel Górgolas Hernández-Mora, Jose M Benito, Norma Rallón
The Era of DAAs: Assessing the Patients' Characteristics, Clinical Impact, and Emergence of Comorbidities in HIV/HCV-Coinfected versus HIV-Infected Individuals. Journal of clinical medicine 13 (13) (2024)
Alberto De la Cuadra-Grande, Jorge Rioja-Zuazu, Mario Domínguez-Esteban, Esperanza Torres, Rob Blissett, Emily Woodward, Itziar Oyagüez, Manuel Fernández-Arjona
Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system. Expert review of pharmacoeconomics & outcomes research (2023)
Alberto De la Cuadra-Grande, Jorge Rioja-Zuazu, Mario Domínguez-Esteban, Esperanza Torres, Rob Blissett, Emily Woodward, Itziar Oyagüez, Manuel Fernández-Arjona
Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system. Expert review of pharmacoeconomics & outcomes research (2023)